Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

562
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
562
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

534
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
534
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

415
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
415
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

363
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
363
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

582
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
582

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same author

Conservative interventions for managing exercise-related musculoskeletal groin pain.

The Cochrane database of systematic reviews·2025
Same author

Evidence for calcium supplementation in pregnancy: More than pre-eclampsia.

BJOG : an international journal of obstetrics and gynaecology·2024
Same author

Surgery for nasal polyposis in cystic fibrosis.

The Cochrane database of systematic reviews·2023
Same author

Prophylactic anticoagulants for non-hospitalised people with COVID-19.

The Cochrane database of systematic reviews·2023
Same author

Digital technology for delivering and monitoring exercise programs for people with cystic fibrosis.

The Cochrane database of systematic reviews·2023
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K

Statins for aortic valve stenosis.

Luciana Thiago1, Selma Rumiko Tsuji, Jonathan Nyong

  • 1Department of Education in Health Sciences, Marilia Medical School, Marilia, Brazil.

The Cochrane Database of Systematic Reviews
|September 6, 2016
PubMed
Summary
This summary is machine-generated.

Statins show uncertain effectiveness for aortic valve stenosis, with evidence quality ranging from moderate to very low. Current guidelines suggest no definitive clinical treatment options are available for this condition.

More Related Videos

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K
Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

4.8K

Related Experiment Videos

Last Updated: Mar 15, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K
Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

4.8K

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Trials

Background:

  • Aortic valve stenosis (AVS) is a prevalent valvular heart disease in the USA and Europe.
  • AVS shares similarities with atherosclerotic disease, prompting investigation into statin efficacy.
  • Previous studies have explored statins as a potential treatment for AVS.

Purpose of the Study:

  • To systematically evaluate the effectiveness and safety of statins in patients with aortic valve stenosis.
  • To synthesize evidence from randomized controlled trials (RCTs) regarding statin use in AVS.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases (CENTRAL, MEDLINE, Embase, LILACS-IBECS, Web of Science, CINAHL Plus) up to November 24, 2015.
  • Included were RCTs comparing statins (alone or with other lipid-lowering agents) against placebo or usual care.
  • Primary outcomes included AVS severity (mean pressure gradient, valve area, aortic jet velocity), freedom from valve replacement, and cardiovascular death. Secondary outcomes encompassed hospitalization, mortality, adverse events, and quality of life.

Main Results:

  • Four RCTs with 2360 participants were analyzed, comparing statins to placebo.
  • Low-quality evidence indicated no significant effect of statins on AVS severity (mean pressure gradient, valve area, aortic jet velocity).
  • Moderate-quality evidence showed no effect on freedom from valve replacement or muscle pain; low to very low-quality evidence demonstrated uncertainty regarding cardiovascular death and hospitalization.

Conclusions:

  • The findings indicate uncertainty about the effectiveness of statins for treating aortic valve stenosis.
  • The evidence quality for reported outcomes was predominantly moderate to very low.
  • These results support current European and USA guidelines suggesting no established clinical treatment for AVS.